BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25103492)

  • 1. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
    Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
    J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for colonization by Clostridium difficile and extended-spectrum β-lactamase-producing Enterobacteriaceae in rehabilitation clinics in Germany.
    Arvand M; Ruscher C; Bettge-Weller G; Goltz M; Pfeifer Y
    J Hosp Infect; 2018 Jan; 98(1):14-20. PubMed ID: 28705583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
    Eibach D; Belmar Campos C; Krumkamp R; Al-Emran HM; Dekker D; Boahen KG; Kreuels B; Adu-Sarkodie Y; Aepfelbacher M; Park SE; Panzner U; Marks F; May J
    Int J Med Microbiol; 2016 Jun; 306(4):249-54. PubMed ID: 27222489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.
    Adler A; Baraniak A; Izdebski R; Fiett J; Salvia A; Samso JV; Lawrence C; Solomon J; Paul M; Lerman Y; Schwartzberg Y; Mordechai E; Rossini A; Fierro J; Lammens C; Malhotra-Kumar S; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M; Carmeli Y;
    Clin Microbiol Infect; 2014 Aug; 20(8):O516-23. PubMed ID: 24450778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mother-to-child transmission of extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
    Danino D; Melamed R; Sterer B; Porat N; Hazan G; Gushanski A; Shany E; Greenberg D; Borer A
    J Hosp Infect; 2018 Sep; 100(1):40-46. PubMed ID: 29330015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.
    Uemura M; Imataki O; Uchida S; Nakayama-Imaohji H; Ohue Y; Matsuka H; Mori H; Dobashi H; Kuwahara T; Kadowaki N
    BMC Infect Dis; 2017 Jan; 17(1):26. PubMed ID: 28056827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.
    Titelman E; Hasan CM; Iversen A; Nauclér P; Kais M; Kalin M; Giske CG
    Clin Microbiol Infect; 2014 Aug; 20(8):O508-15. PubMed ID: 24450760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.
    Tschudin-Sutter S; Frei R; Dangel M; Stranden A; Widmer AF
    Clin Infect Dis; 2012 Dec; 55(11):1505-11. PubMed ID: 22955436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended spectrum beta-lactamase-producing Enterobacteriaceae infections in hematopoietic stem cell transplant recipients: Epidemiology and molecular characterization.
    Kharrat M; Chebbi Y; Ben Tanfous F; Lakhal A; Ladeb S; Othmen TB; Achour W
    Int J Antimicrob Agents; 2018 Dec; 52(6):886-892. PubMed ID: 29783023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
    Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B
    Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-β-lactamase-producing Enterobacteriaceae in Glasgow, Scotland.
    Khanna N; Boyes J; Lansdell PM; Hamouda A; Amyes SG
    J Antimicrob Chemother; 2012 Mar; 67(3):573-7. PubMed ID: 22169188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
    Birgand G; Armand-Lefevre L; Lolom I; Ruppe E; Andremont A; Lucet JC
    Am J Infect Control; 2013 May; 41(5):443-7. PubMed ID: 22998785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
    Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
    Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.
    Arnan M; Gudiol C; Calatayud L; Liñares J; Dominguez MÁ; Batlle M; Ribera JM; Carratalà J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):355-60. PubMed ID: 21052757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period.
    Kola A; Holst M; Chaberny IF; Ziesing S; Suerbaum S; Gastmeier P
    J Hosp Infect; 2007 May; 66(1):46-51. PubMed ID: 17350720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger.
    Woerther PL; Angebault C; Jacquier H; Hugede HC; Janssens AC; Sayadi S; El Mniai A; Armand-Lefèvre L; Ruppé E; Barbier F; Raskine L; Page AL; de Rekeneire N; Andremont A
    Clin Infect Dis; 2011 Oct; 53(7):677-85. PubMed ID: 21890771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.
    Adler A; Baraniak A; Izdebski R; Fiett J; Gniadkowski M; Hryniewicz W; Salvia A; Rossini A; Goossens H; Malhotra S; Lerman Y; Elenbogen M; Carmeli Y;
    Clin Microbiol Infect; 2013 Feb; 19(2):E51-8. PubMed ID: 23210906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.
    Reddy P; Malczynski M; Obias A; Reiner S; Jin N; Huang J; Noskin GA; Zembower T
    Clin Infect Dis; 2007 Oct; 45(7):846-52. PubMed ID: 17806048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.